Skip to main content
. 2023 Sep 6;40:100898. doi: 10.1016/j.lanwpc.2023.100898

Fig. 1.

Fig. 1

Trial Profile. ∗Among 5 patients did not meet eligibility criteria: Active brain metastasis (n = 1), no target lesion (n = 3), and isolated local relapse (n = 1). # Among 7 patients withdrawn due to adverse events: Secondary malignancy (n = 4), skin reaction (n = 2), epistaxis (n = 1).